Further, antibodies to Caspr1/CNTN1 complex were also recognized in a subset of CIDP patients with similar serological and clinical manifestations [45]. This evidence concerns the gene CNTNAP1 and chronic inflammatory demyelinating polyradiculoneuropathy.